Company intelligence / Profile preview

General Genomics

Oklahoma City, Oklahoma, United States

Ownership: Private
Employees: ~7
Development stage: Other

Overview

General Genomics develops AI/ML solutions for healthcare analytics and national security. The company operates a proprietary data lake containing over 600 million records and has three patents pending for machine learning technology designed to identify illnesses and diseases across all living organisms.

Industry: Drug Discovery Services

Partnerships

Moleculera Labs (strategic alliance for developing predictive treatment algorithm for neuropsychiatric disorders)

Beyond the preview

Go deeper on General Genomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on General Genomics.

Explore the full profile